Tenex 2nd Generation System

About Tenex Health

Tenex Health, founded in 2009 and acquired by Trice Medical in 2021, is a commercial-stage medical device company focused on minimally invasive solutions for chronic musculoskeletal pain. Its core technology is the Tenex Health TX System, an ultrasonic platform developed in collaboration with the Mayo Clinic to perform percutaneous tenotomy and remove calcifications and bone spurs. With over 240,000 procedures performed and strong clinical data showing high patient satisfaction, the company targets a large market of patients who have failed conservative treatments but wish to avoid traditional surgery. The recent launch of its 2nd Generation System aims to expand capabilities and procedural efficiency.

About Trice Medical

Trice Medical is a commercial-stage medical device company focused on advancing minimally invasive procedures in orthopedics, sports medicine, and podiatry. Its flagship Tenex system utilizes ultrasonic technology to remove diseased soft tissue for conditions like tendinopathy and plantar fasciitis, offering an alternative to open surgery. The company complements this with the Seg-WAY endoscopic carpal tunnel release system and the mi-eye 3 portable arthroscopy platform. Trice's value proposition centers on simplifying complex procedures, reducing surgical and recovery time, and improving patient outcomes through less invasive techniques.

Therapeutic Areas